Thomas Burmeister

7.8k citations
122 papers · 6.1k · 5 hit papers · h-index 39

Impact in

Papers in

    • Chronic Myeloid Leukemia Treatments 42
    • Acute Myeloid Leukemia Research 35
    • Chronic Lymphocytic Leukemia Research 35

Thomas Burmeister

114 papers receiving 6.0k citations

Thomas Burmeister's Hit Papers

The KMT2A recombinome of acute leukemias in 2023 2023 · 142 citations
1420+5+10Years since publication250500750

Peers

Thomas Burmeister
Comparison fields: 5 of 95
  • Hematology 3.1k
  • Public Health, Environmental and Occupational Health 2.7k
  • Genetics 884
  • Oncology 1.4k
  • Pathology and Forensic Medicine 804
Replace Emmanuelle Clappier with:
Emmanuelle Clappier France
Kimberly P. Dunsmore United States
Jeremy P. Hancock United Kingdom
Helena M. Kempski United Kingdom
Shann-Ching Chen United States
Dirk Nagorsen Germany
Yusuke Oji Japan
Clelia Tiziana Storlazzi Italy
Nobuo Maseki Japan
Arjan Buijs Netherlands
Thomas Burmeister relative to Emmanuelle Clappier France Emmanuelle Clappier's profile →
Citations per field
00.5×1.5×
Emmanuelle Clappier · 1×
Citations per year

Countries citing papers authored by Thomas Burmeister

Since Specialization
Citations

This map shows the geographic impact of Thomas Burmeister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Burmeister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Burmeister more than expected).

Fields of papers citing papers by Thomas Burmeister

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Burmeister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Burmeister. The network helps show where Thomas Burmeister may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Burmeister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Burmeister Line = papers co-authored together Thomas Burmeister links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Hit paper breakdown →
2011780
2
The MLL recombinome of acute leukemias in 2017
Hit paper breakdown →
2017526
3
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Hit paper breakdown →
2012406
4
The MLL recombinome of acute leukemias in 2013
Hit paper breakdown →
2013403
5 2009318
6 2006220
7 2014220
8 2012194
9 2008146
10 2011144
11
The KMT2A recombinome of acute leukemias in 2023
Hit paper breakdown →
2023142
12 2012109
13 200693
14 201487
15 200786
16 200985
17 201382
18 200381
19 201778
20 200975

About Thomas Burmeister

Thomas Burmeister is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Immunology, having authored 122 papers that have together received 6.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (61 papers), Chronic Myeloid Leukemia Treatments (42 papers), Chronic Lymphocytic Leukemia Research (35 papers), Acute Myeloid Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (17 papers), T-cell and Retrovirus Studies (11 papers), Viral-associated cancers and disorders (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Hematology (3.1k citations), Public Health, Environmental and Occupational Health (2.7k citations), Genetics (884 citations), Oncology (1.4k citations) and Pathology and Forensic Medicine (804 citations). Thomas Burmeister has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Stefan Schwartz, Nicola Gökbuget, Eckhard Thiel, Dieter F. Hoelzer, Richard Reinhardt, Claudia Dorothea Baldus, David T. Hoelzer, ECKHARD THIEL, Harald Rieder and E. Thiel. Their work appears in journals such as Blood, Leukemia, Haematologica, Annals of Hematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact